Introduction
We are doctors looking after patients with blood disorders and scientists studying blood conditions in the lab. Our aim is to deliver the best expert and compassionate care for patients with blood diseases and patients who need blood cell transfusions. We want to reduce the burden of disease now and in the future, through our research, services, education, outreach and advocacy.
Our group includes international, scientific and clinical leaders. We draw on our combined expertise to carry out research and develop new services. Through our work we aim to:
- Improve the cost-effectiveness of cancer therapies and the outcomes of treatment – by developing new single cell approaches which tailor treatments to individuals. Find out more
- Improve the management of common and rare anaemias – by studying the role of iron and inflammation in anaemic patients, especially those who are elderly, and by developing a new national NHS service for patients with rare inherited red cell disorders. Find out more
- Improve the outcomes of blood cell and blood component transfusions – by using advanced e-tools and carrying out clinical trials to find out what approaches work best. Find out more
- Involve patients and carers in the key steps of our research projects. Find out more
Related websites
Oxford Centre for Haematology website: rdm.ox.ac.uk/och
RDM – HaemBio Biobank pages:
rdm.ox.ac.uk/about/our-clinical-facilities-and-mrc-units/och/haembio
NSSG website: nssg.oxford-haematology.org.uk
Introductory Talk by Haematology and Stem Cells Theme Lead Professor Paresh Vyas
Dr Susie Shapiro discusses research into thrombosis and COVID-19
In this webinar hosted by Thrombosis UK, BRC Haematology and Stem Cells theme researcher Dr Susie Shapiro speaks about her research on thrombosis in relation to COVID-19.
Follow the Oxford Centre for Haematology on Twitter
Poorer clinical outcomes for black patients with #AML: A wake-up call for better data and greater understanding of cancer outcomes in all ethnic groups. @CD_AACR
Comment: @pvyas_oxford https://t.co/yOeULnfjv8
Article: Bhavana Bhatnagar et al @OSUCCC_James https://t.co/JDqO44rtZI
Recommendation for #WorldBookDay - Dr. Giraffe: Land of the Big: a little story about #leukaemia for children by Rejane Dal Bello @RejaneDalBello and Jayshree Viswanathan @mizvis.
#WorldBookDay2021 @DrGiraffe_Books #ChildhoodCancer https://t.co/8bMVqVepIg
Oxford region & nationwide #MDS support group meeting with @pvyas_oxford and @KirstyCrozier, Friday 5 March 10.30-12.30am. For more information and to register: https://t.co/GkoJK5ZBDS
@MDS_UK @mdsukoxford #MyelodysplasticSyndrome
Addressing the difficult topic of #racism in a safe & collaborative environment, a new #PatientEngagement project aims to increase understanding, reduce stigma & improve quality of life for those living with #sicklecell disease. @noemibaroy @OxfordMedSci https://t.co/trIE2zBNcq
Are you a nurse, midwife or AHP interested in a career in research? Join our online panel discussion with @hewalthall, @cathy_henshall, @SisterMitchell and @louisestrickl to learn more about clinical academic careers on 22 March, 6pm https://t.co/sQI3QeTeqe
Today is #RareDiseasesDay & we're shining a spotlight on chronic myelomonocytic leukaemia (CMML), a rare type of #bloodcancer that we're funding research into:
Whist some blood cancers are rare, collectively they make up more than 20% of all cancer cases.
CMML: Using technology to generate unlimited cells to identify new drugs
Professor Jacqueline Boultwood, University of Oxford and Leukaemia UK Project Grant
ow.ly